← Open Payments lookup

KIMBERLY SNYDER: Open Payments

NPI 1265416341 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$781 in 41 payments from 16 companies in 2025. Trend: 2023 $612 · 2024 $684 · 2025 $781

Food & beverage: $731Long term medical supply or device loan: $50
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$150
Astellas Pharma US Inc5$109
Teva Pharmaceuticals USA, Inc.4$90
Lundbeck LLC4$81
Abbott Laboratories2$69
Novo Nordisk Inc2$40
Neurocrine BioSciences, Inc.2$38
Axsome Therapeutics, Inc.2$37
Amgen Inc.2$37
Eisai Inc.2$32

Products named: CAPLYTA, Veozah, AUSTEDO XR, REXULTI, FREESTYLE INSULINX, INGREZZA, Auvelity, EVENITY.

Industry payments across IN — which companies pay providers there.